Ileocecal resection in Crohn's disease: Our clinical experience

Aim: This study aimed to evaluate the clinical and surgical outcomes of patients undergoing ileocecal resection for Crohn's disease and analyze their postoperative course. Material and Methods: Data from 62 patients who underwent ileocecal resection between January 2014 and February 2022 were retrospectively reviewed. Demographic characteristics, surgery duration, anastomosis configuration, stoma necessity, clinical remission, and postoperative Rutgeerts scores were evaluated. Results: The average age was 40.4 +/- 12.8, and the average age at diagnosis was 32.0 +/- 12.8. The average BMI was 21.48 +/- 3.54. Males comprised 61.3% (n=38) and females 38.7% (n=24). The average surgery duration was 145.6 +/- 61 minutes. Anastomosis was performed on 52 patients. Steroid use (>20mg/day preoperatively) correlated with higher complication rates (50% vs 12%, p<0.05). Active smokers had higher postoperative complication rates. One patient experienced anastomotic leakage. The median Rutgeerts score was 0 (0-4). Recurrence was observed in 12 patients. No significant difference was found between clinical remission and Rutgeerts scores. Post-operative prophylaxis was required in 66.1% (n=41), with 53% starting treatment within 30 days postoperatively. Discussion: Ileocecal resection is an effective and safe treatment for complicated Crohn's disease. Smoking cessation and awareness of increased postoperative complications in patients on high-dose steroids are crucial. Individualized treatment approaches yield satisfactory outcomes.